Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enterovirus 71 (EV71) is a significant human pathogen within the Picornaviridae family, primarily known as a major causative agent of hand, foot, and mouth disease (HFMD) and severe neurological complications in young children (PubMed: 29434377). The viral capsid is an icosahedral shell composed of 60 protomers, each containing four structural proteins: VP1, VP2, VP3, and VP4, which serve to protect the viral RNA and facilitate host cell entry (UniProt: P03300). VP1 is the most surface-exposed protein and plays a critical role in binding to host receptors such as SCARB2 and PSGL-1 (PubMed: 22437571). Because these capsid proteins are essential for the initial stages of the viral life cycle, they are primary targets for antiviral drug development and vaccine design. Small-molecule inhibitors, known as capsid binders, typically lodge in a hydrophobic pocket in VP1 to prevent viral uncoating, while inactivated and recombinant vaccines utilize these proteins to elicit protective neutralizing antibodies (PubMed: 25108375, PubMed: 24581533).
Capsid binders interact with a hydrophobic pocket (often referred to as the canyon) located within the VP1 protein; this interaction stabilizes the viral capsid and prevents the conformational changes required for viral uncoating and the subsequent release of the viral RNA genome into the host cell (PubMed: 25108375, PubMed: 22437571).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterovirus 71 viral capsid proteins (EV71 capsid proteins).